iSpecimen Inc.
No SEC Form 4 filings for $ISPC in the last 30 days.
iSpecimen Inc. (ISPC) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.2 4 ea030100601ex10-2.htm FORM OF SECURITIES PURCHASE AGREEMENT Exhibit 10.2 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of [*], 2026, between iSpecimen Inc., a Delaware corporation (the “Company”), and each purchaser iden
iSpecimen Inc. (NASDAQ:ISPC) announced it secured approximately $5.5 million in funding through a private placement of Series C Convertible Preferred Stock with accredited investors. The company plans to use the net proceeds for marketing, working capital, and general corporate purposes, with the offering expected to close around December 31, 2025. This funding comes as iSpecimen addresses potential cash burn concerns and recent Nasdaq non-compliance notice regarding its minimum bid price, alongside shareholder approval of a reverse stock split.
iSpecimen Inc. (NASDAQ: ISPC) announced a private placement aiming to raise approximately $5.5 million by issuing 6,875 shares of Series C Convertible Preferred Stock at $800 each. The net proceeds are intended for marketing, working capital, and general corporate purposes, with the closing expected around December 31, 2025. Following the announcement, iSpecimen's stock gained 39.96%, indicating a significant positive market reaction.
Over the past 7 days, alphai's AI scored 1 news story mentioning ISPC (iSpecimen Inc.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent ISPC coverage spans financial news and corporate actions.
The filing indicates ISPC has entered a definitive agreement to issue and sell securities, which can dilute existing holders and change near-term funding expectations.
The company's recent $5.5 million funding round indicates ongoing investor confidence, despite recent Nasdaq non-compliance issues. This infusion of capital may support operational stability and strategic initiatives.
The announcement of a $5.5 million private placement by iSpecimen Inc. has led to a nearly 40% increase in its stock price, indicating strong investor confidence. The infusion of capital is intended for marketing and operational expansion, which could support future growth.
The successful closing of a $1.75 million private placement indicates positive financial activity, potentially supporting growth initiatives.
The announcement of a private placement at-the-market suggests a capital raise, which could lead to dilution of existing shares. Short-term traders might see increased volatility, while long-term investors should assess the company's use of proceeds.
alphai scores every news story that mentions ISPC with an AI model for sentiment and relevance, and aggregates insider trades from iSpecimen Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
iSpecimen Inc. (ISPC) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.2 4 ea030100601ex10-2.htm FORM OF SECURITIES PURCHASE AGREEMENT Exhibit 10.2 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of [*], 2026, between iSpecimen Inc., a Delaware corporation (the “Company”), and each purchaser iden
4 min readiSpecimen Inc. (NASDAQ:ISPC) announced it secured approximately $5.5 million in funding through a private placement of Series C Convertible Preferred Stock with accredited investors. The company plans to use the net proceeds for marketing, working capital, and general corporate purposes, with the offering expected to close around December 31, 2025. This funding comes as iSpecimen addresses potential cash burn concerns and recent Nasdaq non-compliance notice regarding its minimum bid price, alongside shareholder approval of a reverse stock split.
4 min readiSpecimen Inc. (NASDAQ: ISPC) announced a private placement aiming to raise approximately $5.5 million by issuing 6,875 shares of Series C Convertible Preferred Stock at $800 each. The net proceeds are intended for marketing, working capital, and general corporate purposes, with the closing expected around December 31, 2025. Following the announcement, iSpecimen's stock gained 39.96%, indicating a significant positive market reaction.
2 min readWOBURN, Mass., Aug. 04, 2025 ( GLOBE NEWSWIRE ) -- iSpecimen Inc. ( Nasdaq: ISPC ) ( "iSpecimen" or the "Company" ) , an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it closed ...
2 min readWOBURN, Mass., July 31, 2025 ( GLOBE NEWSWIRE ) -- iSpecimen Inc. ( Nasdaq: ISPC ) ( "iSpecimen" or the "Company" ) , an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it entered ...
2 min readWOBURN, Mass., July 28, 2025 ( GLOBE NEWSWIRE ) -- This press release corrects a version issued on July 25, 2025 that incorrectly listed KCSA Strategic Communications as iSpecimen's investor relations contact. KCSA is not currently affiliated with iSpecimen Inc. and was mistakenly included in the ...
2 min readWOBURN, Mass., July 28, 2025 ( GLOBE NEWSWIRE ) -- This press release corrects a version issued on July 25, 2025 that incorrectly listed KCSA Strategic Communications as iSpecimen's investor relations contact. KCSA is not currently affiliated with iSpecimen Inc. and was mistakenly included in the ...
2 min readWOBURN, Mass., July 28, 2025 ( GLOBE NEWSWIRE ) -- This press release corrects the version issued on July 24, 2025 that incorrectly listed KCSA Strategic Communications as iSpecimen's investor relations contact. KCSA is not currently affiliated with iSpecimen Inc. and was mistakenly included in ...
2 min readWOBURN, Mass., July 25, 2025 ( GLOBE NEWSWIRE ) -- iSpecimen Inc. ( Nasdaq: ISPC ) ( "iSpecimen" or the "Company" ) , an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today the closing of ...
2 min readWOBURN, Mass., July 25, 2025 ( GLOBE NEWSWIRE ) -- iSpecimen Inc.
3 min read
